Influence of glucose supplementation and inoculum size on growth kinetics and antifungal susceptibility testing of Candida spp
about
Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility.Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.Standardization of antifungal susceptibility variables for a semiautomated methodology.Antifungal susceptibility testing: practical aspects and current challenges.Detection of resistance to amphotericin B in Candida isolates by using Iso-Sensitest broth.International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailinComparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of candida species.Transient fungemia caused by an amphotericin B-resistant isolate of Candida haemulonii.Aspergillus fumigatus C-5 sterol desaturases Erg3A and Erg3B: role in sterol biosynthesis and antifungal drug susceptibility.Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.In vitro activities of three licensed antifungal agents against spanish clinical isolates of Aspergillus spp.Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemiaRapid detection of triazole antifungal resistance in Aspergillus fumigatus.In Vitro Susceptibility and Trailing Growth Effect of Clinical Isolates of Candida Species to Azole Drugs.Antifungal susceptibility testing: a primer for clinicians.Progressive development in experimental models of transungual drug delivery of anti-fungal agents.The HIV aspartyl protease inhibitor ritonavir impairs planktonic growth, biofilm formation and proteolytic activity in Trichosporon spp.Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibilitReliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.Statistical analyses of correlation between fluconazole MICs for Candida spp. assessed by standard methods set forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2)Novel antifungal activity of purpurin against Candida species in vitro.Environmental strains of Cryptococcus neoformans variety grubii in the city of Santos, SP, Brazil.Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.Effect of physiological heterogeneity of E. coli population on antibiotic susceptivity test.
P2860
Q33836567-7935BFBA-F6AD-4720-9877-4A341C5D7377Q33857685-826143C0-8C33-418E-9F32-C923D9327958Q33972874-8625C8AF-62D3-437C-BCF0-E77FF3900004Q33975757-4550651A-F9F0-44BF-A06F-7A3375989402Q33982529-71375FFE-FE98-4956-AE9B-DE4A480B5289Q34041596-06723243-35E8-419C-B646-5D24BA7D0C43Q34110565-03F27A33-AFAA-475F-8D57-9774A9E722EFQ34142465-C146481B-E040-49CF-B2CA-F42876223D99Q34196084-D837C422-C2EC-4F22-B885-E09653583243Q34352270-7AE40E9B-145E-4BB8-9EFD-8993442B8FA4Q35635472-F5C4D2F7-5BD8-427F-9507-38D9AC362BDDQ36047931-98332FCD-50D2-4A99-BB80-22C3AE259AA1Q36094974-70965953-768B-4149-8045-D6F29E76F928Q36539892-8F455451-2765-451A-B771-7B165E783124Q36828123-F71CA811-B658-4EFE-B517-16403B19F8F3Q38061087-F85A52C8-488D-4735-BD18-BC25C83FBAB6Q38446060-D643F78A-4CE8-49D2-8AA7-D2A462CF4462Q38953226-52A1EE73-18C8-437D-8676-4F1FF7BC297EQ39665005-ACE1548F-60E2-4381-B953-8134FBB11071Q41872556-50DD69CD-5BD5-476B-93D8-C09584013597Q42132063-E371A812-F97C-41ED-A955-D12A05C9415EQ43099651-4832A825-C3CA-4DD0-92E3-F15B1B7F8064Q45281493-6029A914-2792-4B47-8E63-169675918698Q46865944-6DCCB017-AB45-4BF0-8D44-A6B877CAB7D7Q46976932-0A45F380-65E7-442F-9E2C-D9150C915C11
P2860
Influence of glucose supplementation and inoculum size on growth kinetics and antifungal susceptibility testing of Candida spp
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Influence of glucose supplemen ...... ibility testing of Candida spp
@ast
Influence of glucose supplemen ...... ibility testing of Candida spp
@en
type
label
Influence of glucose supplemen ...... ibility testing of Candida spp
@ast
Influence of glucose supplemen ...... ibility testing of Candida spp
@en
prefLabel
Influence of glucose supplemen ...... ibility testing of Candida spp
@ast
Influence of glucose supplemen ...... ibility testing of Candida spp
@en
P2093
P2860
P1476
Influence of glucose supplemen ...... ibility testing of Candida spp
@en
P2093
J L Rodríguez-Tudela
M Cuenca-Estrella
T M Díaz-Guerra
P2860
P304
P356
10.1128/JCM.39.2.525-532.2001
P407
P577
2001-02-01T00:00:00Z